Academic Bibliography

 Search 200 years of publications by Ghent University researchers.
Advanced search
1 file | 3.60 MB
Add to list
  1. Search results
  2. The role of mRNA-galsomes and LNPs in...

The role of mRNA-galsomes and LNPs in enhancing HIV-specific T cell responses across various lymphoid organs

Sigrid D’haese, Sabine den Roover, Rein Verbeke (UGent) , Ilke Aernout (UGent) , Sofie Meulewater, Joëlle Cosyns, Jessy Meert, Sarah Vanbellingen, Thessa Laeremans, Ine Lentacker (UGent) , et al.
(2024) MOLECULAR THERAPY NUCLEIC ACIDS. 35(4).
Author
Organization
Project
Abstract
mRNA nanoparticles have been investigated in the context of prophylactic vaccination against HIV, but their effectivity has not been widely investigated in therapeutic vaccination. It has been suggested that a profound CD8+ T cell response within lymphoid tissues, a primary site for viral reservoirs, is crucial for achieving optimal viral control, potentially correlating with protection. This study aimed to evaluate the effectiveness of mRNA lipid nanoparticles (LNPs), including a modified variant containing a-galactosylceramide as an adjuvant, termed galsomes. C57BL/6 mice were immunized intramuscularly with nucleoside-modified mRNA encoding ovalbumin (li80tOVA), revealing that mRNA-galsomes induced slightly higher proliferation levels of li80tOVA-specific CD8+ T cells in lymphoid tissues across various anatomical sites compared with mRNA-LNPs. In addition, immunization with nucleoside-modified HIV-1 Gag mRNA elicited a notable Gag-specific immune response in both formulations even at low mRNA doses. Remarkably, mRNA-galsomes induced lower polyfunctional responses in CD4+ T cells, but similar poly- functional responses in CD8+ T cells in the spleen compared with mRNA-LNPs. Importantly, the Gag-specific CD8+ T cells demonstrated cytolytic capacity against target cells in both the spleen and lymphoid tissues, including gut-associated lymph nodes. These fi ndings underscore the potential of both mRNA-galsomes and mRNA-LNPs as tools for therapeutic vaccination against HIV.
Keywords
DENDRITIC CELLS, NKT CELLS, ELITE CONTROLLERS, IMMUNE-RESPONSES, ACTIVATION, EXPRESSION, VACCINES, INDUCTION, INFECTION, ADJUVANT

Downloads

  • Download
    PIIS2162253124002592.pdf
    • full text (Published version)
    • |
    • open access
    • |
    • PDF
    • |
    • 3.60 MB

Citation

Please use this url to cite or link to this publication:

MLA
D’haese, Sigrid, et al. “The Role of MRNA-Galsomes and LNPs in Enhancing HIV-Specific T Cell Responses across Various Lymphoid Organs.” MOLECULAR THERAPY NUCLEIC ACIDS, vol. 35, no. 4, 2024, doi:10.1016/j.omtn.2024.102372.
APA
D’haese, S., den Roover, S., Verbeke, R., Aernout, I., Meulewater, S., Cosyns, J., … Aerts, J. L. (2024). The role of mRNA-galsomes and LNPs in enhancing HIV-specific T cell responses across various lymphoid organs. MOLECULAR THERAPY NUCLEIC ACIDS, 35(4). https://doi.org/10.1016/j.omtn.2024.102372
Chicago author-date
D’haese, Sigrid, Sabine den Roover, Rein Verbeke, Ilke Aernout, Sofie Meulewater, Joëlle Cosyns, Jessy Meert, et al. 2024. “The Role of MRNA-Galsomes and LNPs in Enhancing HIV-Specific T Cell Responses across Various Lymphoid Organs.” MOLECULAR THERAPY NUCLEIC ACIDS 35 (4). https://doi.org/10.1016/j.omtn.2024.102372.
Chicago author-date (all authors)
D’haese, Sigrid, Sabine den Roover, Rein Verbeke, Ilke Aernout, Sofie Meulewater, Joëlle Cosyns, Jessy Meert, Sarah Vanbellingen, Thessa Laeremans, Ine Lentacker, and Joeri L. Aerts. 2024. “The Role of MRNA-Galsomes and LNPs in Enhancing HIV-Specific T Cell Responses across Various Lymphoid Organs.” MOLECULAR THERAPY NUCLEIC ACIDS 35 (4). doi:10.1016/j.omtn.2024.102372.
Vancouver
1.
D’haese S, den Roover S, Verbeke R, Aernout I, Meulewater S, Cosyns J, et al. The role of mRNA-galsomes and LNPs in enhancing HIV-specific T cell responses across various lymphoid organs. MOLECULAR THERAPY NUCLEIC ACIDS. 2024;35(4).
IEEE
[1]
S. D’haese et al., “The role of mRNA-galsomes and LNPs in enhancing HIV-specific T cell responses across various lymphoid organs,” MOLECULAR THERAPY NUCLEIC ACIDS, vol. 35, no. 4, 2024.
@article{01JHF8QM4BPMDCQ4D1Q2H72RPT,
  abstract     = {{mRNA nanoparticles have been investigated in the context of prophylactic vaccination against HIV, but their effectivity has not been widely investigated in therapeutic vaccination. It has been suggested that a profound CD8+ T cell response within lymphoid tissues, a primary site for viral reservoirs, is crucial for achieving optimal viral control, potentially correlating with protection. This study aimed to evaluate the effectiveness of mRNA lipid nanoparticles (LNPs), including a modified variant containing a-galactosylceramide as an adjuvant, termed galsomes. C57BL/6 mice were immunized intramuscularly with nucleoside-modified mRNA encoding ovalbumin (li80tOVA), revealing that mRNA-galsomes induced slightly higher proliferation levels of li80tOVA-specific CD8+ T cells in lymphoid tissues across various anatomical sites compared with mRNA-LNPs. In addition, immunization with nucleoside-modified HIV-1 Gag mRNA elicited a notable Gag-specific immune response in both formulations even at low mRNA doses. Remarkably, mRNA-galsomes induced lower polyfunctional responses in CD4+ T cells, but similar poly- functional responses in CD8+ T cells in the spleen compared with mRNA-LNPs. Importantly, the Gag-specific CD8+ T cells demonstrated cytolytic capacity against target cells in both the spleen and lymphoid tissues, including gut-associated lymph nodes. These fi ndings underscore the potential of both mRNA-galsomes and mRNA-LNPs as tools for therapeutic vaccination against HIV.}},
  articleno    = {{102372}},
  author       = {{D’haese, Sigrid and den Roover, Sabine and Verbeke, Rein and Aernout, Ilke and Meulewater, Sofie and Cosyns, Joëlle and Meert, Jessy and Vanbellingen, Sarah and Laeremans, Thessa and Lentacker, Ine and Aerts, Joeri L.}},
  issn         = {{2162-2531}},
  journal      = {{MOLECULAR THERAPY NUCLEIC ACIDS}},
  keywords     = {{DENDRITIC CELLS,NKT CELLS,ELITE CONTROLLERS,IMMUNE-RESPONSES,ACTIVATION,EXPRESSION,VACCINES,INDUCTION,INFECTION,ADJUVANT}},
  language     = {{eng}},
  number       = {{4}},
  pages        = {{13}},
  title        = {{The role of mRNA-galsomes and LNPs in enhancing HIV-specific T cell responses across various lymphoid organs}},
  url          = {{http://doi.org/10.1016/j.omtn.2024.102372}},
  volume       = {{35}},
  year         = {{2024}},
}
Altmetric
View in Altmetric
Web of Science
Times cited: